Behavioural effects of the ACE insertion/deletion polymorphism in Alzheimer’s disease depend upon stratification according to APOE-ϵ4 carrier status

References

• Almeida, S. S., Barros, C. C., Moraes, M. R., Russo, F. J., Haro, A. S., Rosa, T. S., Alves, M. F., Pesquero, J. B., Carmona, A. K., Bacurau, R. F. P., & Araújo, R. C. (2010). Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphism. Neuropeptides, 44(2), 139–143. https://doi.org/10.1016/j.npep.2009.12.003
   PubMed Web of Science ®Google Scholar
• Alvarez, R., Alvarez, V., Lahoz, C. H., Martinez, C., Pena, J., Sánchez, J. M., Guisasola, L. M., Salas-Puig, J., Morís, G., Vidal, J. A., Ribacoba, R., Menes, B. B., Uría, D., & Coto, E. (1999). Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 67(6), 733–736. https://doi.org/10.1136/jnnp.67.6.733
   PubMed Web of Science ®Google Scholar
• Annerbrink, K., Jönsson, E. G., Olsson, M., Nilsson, S., Sedvall, G. C., Anckarsäter, H., & Ericksson, E. (2010). Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid. Psychiatry Research, 179(2), 231–234. https://doi.org/10.1016/j.psychres.2009.04.018
   PubMed Web of Science ®Google Scholar
• Arinami, T., Li, L., Mitsushio, H., Itokawa, M., Hamaguchi, H., & Toru, M. (1996). An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biological Psychiatry, 40(11), 1122–1127. https://doi.org/10.1016/S0006-3223(95)00597-8
   PubMed Web of Science ®Google Scholar
• Camozzatto, A. L., Kochhann, R., Simeoni, C., Konrath, C. A., Franz, A. P., Carvalho, A., & Chaves, M. L. (2008). Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer’s disease and their caregivers. International Psychogeriatrics, 20(2), 383–393. https://doi.org/10.1017/S1041610207006254
   Web of Science ®Google Scholar
• Chaves, M. L. F., Camozzato, A. L., Godinho, C., Kochhann, R., Schuh, A., Almeida, V. L., & Kaye, J. (2007). Validity of the Clinical Dementia Rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Disease & Associated Disorders, 21(3), 210–217. https://doi.org/10.1097/WAD.0b013e31811ff2b4
   PubMed Web of Science ®Google Scholar
• Delano-Wood, L., Houston, W. S., Emond, J. A., Marchant, N. L., Salmon, D. P., Jeste, D. V., Thal, L. J., & Bondi, M. W. (2008). APOE genotype predicts depression in women with Alzheimer’s disease: A retrospective study. International Journal of Geriatric Psychiatry, 23(6), 632–636. https://doi.org/10.1002/gps.1953
   PubMed Web of Science ®Google Scholar
• De Oliveira, F. F., Berretta, J. M., Almeida Junior, G. V., Almeida, S. S., Chen, E. S., Smith, M. C., & Bertolucci, P. H. F. (2019). Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer’s dementia. Indian Journal of Medical Research, 150(3), 261–271. https://doi.org/10.4103/ijmr.IJMR_1209_17
   PubMed Web of Science ®Google Scholar
• De Oliveira, F. F., Bertolucci, P. H. F., Chen, E. S., & Smith, M. A. C. (2014b). Assessment of sleep satisfaction in patients with dementia due to Alzheimer’s disease. Journal of Clinical Neuroscience, 21(12), 2112–2117. https://doi.org/10.1016/j.jocn.2014.05.041
   PubMed Web of Science ®Google Scholar
• De Oliveira, F. F., Bertolucci, P. H. F., Chen, E. S., & Smith, M. A. C. (2014c). Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer’s disease. Journal of the Neurological Sciences, 336(1-2), 103–108. https://doi.org/10.1016/j.jns.2013.10.015
   PubMed Web of Science ®Google Scholar
• De Oliveira, F. F., Bertolucci, P. H. F., Chen, E. S., & Smith, M. C. (2014a). Risk factors for age at onset of dementia due to Alzheimer’s disease in a sample of patients with low mean schooling from São Paulo, Brazil. International Journal of Geriatric Psychiatry, 29(10), 1033–1039. https://doi.org/10.1002/gps.4094
   PubMed Web of Science ®Google Scholar
• De Oliveira, F. F., Chen, E. S., Smith, M. C., & Bertolucci, P. H. F. (2016). Associations of blood pressure with functional and cognitive changes in patients with Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 41(5-6), 314–323. https://doi.org/10.1159/000447585
   PubMed Web of Science ®Google Scholar
• De Oliveira, F. F., Chen, E. S., Smith, M. C., & Bertolucci, P. H. F. (2018). Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer’s disease dementia. Current Alzheimer Research, 15(4), 386–398. https://doi.org/10.2174/1567205014666171016101816
   PubMed Web of Science ®Google Scholar
• De Oliveira, F. F., Miraldo, M. C., Castro-Neto, E. F., Almeida, S. S., Matas, S. L. A., Bertolucci, P. H. F., & Naffah-Mazzacoratti, M. G. (2021). Associations of neuropsychiatric features with cerebrospinal fluid biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s disease and cognitively healthy people. Journal of Alzheimer’s Disease, https://doi.org/10.3233/JAD-210272
   Google Scholar
• Elkins, J. S., Douglas, V. C., & Johnston, S. C. (2004). Alzheimer disease risk and genetic variation in ACE: A meta-analysis. Neurology, 62(3), 363–368. https://doi.org/10.1212/01.WNL.0000106823.72493.FF
   PubMed Web of Science ®Google Scholar
• Haj, M. E., Gallouj, K., Dehon, H., Roche, J., & Larøi, F. (2018). Hallucinations in Alzheimer's disease: Failure to suppress irrelevant memories. Cognitive Neuropsychiatry, 23(3), 142–153. https://doi.org/10.1080/13546805.2018.1443062
   PubMed Web of Science ®Google Scholar
• Hsieh, S. W., Liu, M. W., Huang, L. C., Wu, M. N., & Yang, Y. N. (2019). The impact of angiotensin-converting Enzyme Gene on behavioral and psychological symptoms of dementia in Alzheimer’s disease. Current Alzheimer Research, 16(14), 1269–1275. https://doi.org/10.2174/1567205017666200103114550
   PubMed Web of Science ®Google Scholar
• Jellinger, K. A. (2005). Understanding the pathology of vascular cognitive impairment. Journal of the Neurological Sciences, 229–230. 57-63. https://doi.org/10.1016/j.jns.2004.11.029
   Web of Science ®Google Scholar
• Kalaria, R. J., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004). Towards defining the neuropathological substrates of vascular dementia. Journal of the Neurological Sciences, 226(1-2), 75–80. https://doi.org/10.1016/j.jns.2004.09.019
   PubMed Web of Science ®Google Scholar
• Katzov, H., Bennet, A. M., Kehoe, P., Wiman, B., Gatz, M., Blennow, K., Lenhard, B., Pedersen, N. L., de Faire, U., & Prince, J. A. (2004). A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Human Molecular Genetics, 13(21), 2647–2657. https://doi.org/10.1093/hmg/ddh286
   PubMed Web of Science ®Google Scholar
• Kehoe, P. G. (2018). The coming of age of the angiotensin hypothesis in Alzheimer’s disease: Progress toward disease prevention and treatment? Journal of Alzheimer's Disease, 62(3), 1443–1466. https://doi.org/10.3233/JAD-171119
   PubMed Web of Science ®Google Scholar
• Koppel, J., & Goldberg, T. (2009). The genetics of episodic memory. Cognitive Neuropsychiatry, 14(4-5), 356–376. https://doi.org/10.1080/13546800902990438
   PubMedGoogle Scholar
• Loeb, C., & Gandolfo, C. (1983). Diagnostic evaluation of degenerative and vascular dementia. Stroke, 14(3), 399–401. https://doi.org/10.1161/01.STR.14.3.399
   PubMed Web of Science ®Google Scholar
• McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack Jr, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carillo, M. C., Thies, B., Weintraub, S., & Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimer’s & Dementia, 7(3), 263–269. https://doi.org/10.1016/j.jalz.2011.03.005
   PubMed Web of Science ®Google Scholar
• Miners, J. S., Baig, S., Palmer, J., Palmer, L. E., Kehoe, P. G., & Love, S. (2008). Aβ-Degrading enzymes in Alzheimer’s disease. Brain Pathology, 18(2), 240–252. https://doi.org/10.1111/j.1750-3639.2008.00132.x
   PubMed Web of Science ®Google Scholar
• Oliveira, F. F., Chen, E. S., Smith, M. C., & Bertolucci, P. H. (2017). Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer’s disease dementia. Revista Brasileira de Psiquiatria, 39(2), 95–103. https://doi.org/10.1590/1516-4446-2016-1991
   PubMed Web of Science ®Google Scholar
• Ouk, M., Wu, C. Y., Rabin, J. S., Jackson, A., Edwards, J. D., Ramirez, J., Masellis, M., Swartz, R. H., Herrmann, N., Lanctôt, K. L., Black, S. E., & Swardfager, W. (2021). The use of angiotensin-converting enzyme inhibitors vs. Angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: The importance of blood-brain barrier penetration and APOE ϵ4 carrier status. Alzheimer’s Research & Therapy, 13(1), 43. https://doi.org/10.1186/s13195-021-00778-8
   PubMed Web of Science ®Google Scholar
• Panza, F., Capurso, C., D’Introno, A., Kehoe, P. G., Seripa, D., Pilotto, A., Capurso, A., & Solfrizzi, V. (2007). Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages. Atherosclerosis, 193(2), 455–457. https://doi.org/10.1016/j.atherosclerosis.2006.08.040
   PubMed Web of Science ®Google Scholar
• Schmidt, C., Wolff, M., von Ahsen, N., & Zerr, I. (2012). Alzheimer’s disease: Genetic polymorphisms and rate of decline. Dementia and Geriatric Cognitive Disorders, 33(2-3), 84–89. https://doi.org/10.1159/000336790
   PubMed Web of Science ®Google Scholar
• Seripa, D., Dal Forno, G., Matera, M. G., Gravina, C., Margaglione, M., Palermo, M. T., Wekstein, D. R., Antuono, P., Davis, D. G., Daniele, A., Masullo, C., Bizzarro, A., Gennarelli, M., & Fazio, V. M. (2003). Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiology of Aging, 24(7), 933–939. https://doi.org/10.1016/S0197-4580(03)00040-X
   PubMed Web of Science ®Google Scholar
• Sleegers, K., den Heijera, T., van Dijka, E. J., Hofman, A., Bertoli-Avella, A. M., Koudstaal, P. J., Breteler, M. M. B., & van Duijn, C. M. (2005). ACE gene is associated with Alzheimer’s disease and atrophy of hippocampus and amygdale. Neurobiology of Aging, 26(8), 1153–1159. https://doi.org/10.1016/j.neurobiolaging.2004.09.011
   PubMed Web of Science ®Google Scholar
• Tian, J., Shia, J., Baileya, K., Harris, J. M., Pritchard, A., Lambert, J. C., Chartier-Harlin, M. C., Pickering-Brown, S. M., Lendon, C. L., & Mann, D. M. A. (2004). A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer’s disease. Neuroscience Letters, 354(2), 103–106. https://doi.org/10.1016/j.neulet.2003.09.072
   PubMed Web of Science ®Google Scholar
• Wang, B., Jin, F., Yang, Z., Lu, Z., Kan, R., Li, S., Zheng, C., & Wang, L. (2006). The insertion polymorphism in Angiotensin-Converting Enzyme Gene associated With the APOE ϵ4 allele increases the risk of late-onset Alzheimer disease. Journal of Molecular Neuroscience, 30(3), 267–272. https://doi.org/10.1385/JMN:30:3:267
   PubMed Web of Science ®Google Scholar
• Yang, Y. H., & Liu, C. K. (2008). Angiotensin-Converting Enzyme Gene in Alzheimer’s disease. The Tohoku Journal of Experimental Medicine, 215(4), 295–298. https://doi.org/10.1620/tjem.215.295
   PubMed Web of Science ®Google Scholar